Cargando…

Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples

Antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) for HIV-serodiscordant couples, effectively reduce mortality, transmission events and influence quality of life at the expense of increased costs. We aimed to evaluate health economics of antiretroviral-based strategies for HIV-serod...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Haisheng, Yu, Qiuyan, Ma, Liping, Zhang, Lin, Chen, Yuliang, Guo, Pi, Xu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263699/
https://www.ncbi.nlm.nih.gov/pubmed/34234232
http://dx.doi.org/10.1038/s41598-021-93443-x
_version_ 1783719426840854528
author Wu, Haisheng
Yu, Qiuyan
Ma, Liping
Zhang, Lin
Chen, Yuliang
Guo, Pi
Xu, Peng
author_facet Wu, Haisheng
Yu, Qiuyan
Ma, Liping
Zhang, Lin
Chen, Yuliang
Guo, Pi
Xu, Peng
author_sort Wu, Haisheng
collection PubMed
description Antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) for HIV-serodiscordant couples, effectively reduce mortality, transmission events and influence quality of life at the expense of increased costs. We aimed to evaluate health economics of antiretroviral-based strategies for HIV-serodiscordant couples in the China context. A deterministic model of HIV evolution and transmission within a cohort of serodiscordant couples was parameterized using the real-world database of Zhoukou city and published literature. We evaluated the mid-ART (a historical strategy, initiating ART with CD4 < 500 cells/mm(3)), early-ART (the current strategy, offering ART regardless of CD4 cell counts) and a hypothetical strategy (early-ART combined short-term daily PrEP) versus the late-ART (the baseline strategy, initiating ART with CD4 < 350 cells/mm(3)) offered by 2008 national guidelines. We estimated the incremental cost-effectiveness ratios (ICER) and incremental cost-utility ratios (ICUR) from a societal perspective, derived by clinical benefits and HIV-caused life quality respectively, and portrayed their changes over a 0–30 year’s timeframe. The model projections indicated that the antiretroviral-based interventions were more likely to obtain clinical benefits but difficult to improve quality of life, and cumulative ICER and ICUR were generally decreasing without achieving cost-saving. Scale-up access to ART for the HIV-positive among serodiscordant couples was easily fallen within the range of paying for incremental life-years and quality adjusted life years by the societal willingness. The hypothetical strategy had the potential to prevent most seroconversion events within marriages but required enormous upfront costs, thus it took a long time to reach established thresholds. The current strategy of early-ART is the most cost-effective. Clarifying the obstacles of high cost of PrEP and improving life quality for HIV-serodiscordant couples have emerged as an urgent requisition.
format Online
Article
Text
id pubmed-8263699
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82636992021-07-09 Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples Wu, Haisheng Yu, Qiuyan Ma, Liping Zhang, Lin Chen, Yuliang Guo, Pi Xu, Peng Sci Rep Article Antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) for HIV-serodiscordant couples, effectively reduce mortality, transmission events and influence quality of life at the expense of increased costs. We aimed to evaluate health economics of antiretroviral-based strategies for HIV-serodiscordant couples in the China context. A deterministic model of HIV evolution and transmission within a cohort of serodiscordant couples was parameterized using the real-world database of Zhoukou city and published literature. We evaluated the mid-ART (a historical strategy, initiating ART with CD4 < 500 cells/mm(3)), early-ART (the current strategy, offering ART regardless of CD4 cell counts) and a hypothetical strategy (early-ART combined short-term daily PrEP) versus the late-ART (the baseline strategy, initiating ART with CD4 < 350 cells/mm(3)) offered by 2008 national guidelines. We estimated the incremental cost-effectiveness ratios (ICER) and incremental cost-utility ratios (ICUR) from a societal perspective, derived by clinical benefits and HIV-caused life quality respectively, and portrayed their changes over a 0–30 year’s timeframe. The model projections indicated that the antiretroviral-based interventions were more likely to obtain clinical benefits but difficult to improve quality of life, and cumulative ICER and ICUR were generally decreasing without achieving cost-saving. Scale-up access to ART for the HIV-positive among serodiscordant couples was easily fallen within the range of paying for incremental life-years and quality adjusted life years by the societal willingness. The hypothetical strategy had the potential to prevent most seroconversion events within marriages but required enormous upfront costs, thus it took a long time to reach established thresholds. The current strategy of early-ART is the most cost-effective. Clarifying the obstacles of high cost of PrEP and improving life quality for HIV-serodiscordant couples have emerged as an urgent requisition. Nature Publishing Group UK 2021-07-07 /pmc/articles/PMC8263699/ /pubmed/34234232 http://dx.doi.org/10.1038/s41598-021-93443-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Wu, Haisheng
Yu, Qiuyan
Ma, Liping
Zhang, Lin
Chen, Yuliang
Guo, Pi
Xu, Peng
Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples
title Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples
title_full Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples
title_fullStr Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples
title_full_unstemmed Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples
title_short Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples
title_sort health economics modeling of antiretroviral interventions amongst hiv serodiscordant couples
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263699/
https://www.ncbi.nlm.nih.gov/pubmed/34234232
http://dx.doi.org/10.1038/s41598-021-93443-x
work_keys_str_mv AT wuhaisheng healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples
AT yuqiuyan healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples
AT maliping healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples
AT zhanglin healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples
AT chenyuliang healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples
AT guopi healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples
AT xupeng healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples